Ionis and partner announce enrollment completion of global Phase 3 GENERATION...

What does COVID-19 mean for Huntington’s disease families and HD research?

New molecule can reverse the Huntington’s disease mutation in lab models

Huntington’s disease therapeutics conference 2020 – Day 3

CHDI head scientist Pacifici: ‘hang on in the learning roller coaster...

Huntington’s disease therapeutics conference 2020 – Day 2

At Therapeutics Conference, landmark study of young gene carriers highlights how...

Huntington’s disease therapeutics conference 2020 – Day 1

uniQure Presents Multiple New Preclinical Data on AMT-130 at the CHDI’s...

Huntington’s disease-causing DNA repeat mutations reversed in the lab

1234...126Page 3 of 126